Partner Research Centers:


Institute on Aging

Penn Medicine Town Hall Meeting

A Discussion on Alzheimer's, BRAIN Initiative, and other Major Funding Opportunities

On Wednesday, June 1, 2016, the University of Pennsylvania Perelman School of Medicine’s Institute on Aging (IOA), Center for Neurodegenerative Disease Research (CNDR), and Penn Translational Neuroscience Center (PTNC) co-hosted their first Town Hall Meeting, open to all interested University of Pennsylvania researchers.

The idea behind this joint effort is to increase the awareness and knowledge of the
variety of available National Institutes of Health (NIH) funding opportunities relating
to Alzheimer’s disease and related disorders (ADRD) and the neurosciences, with many already underway here at Penn.

“In the last five years, NIH funding [for ADRD research] increased from $450 million
to nearly $1 billion,” explained John Q. Trojanowski, MD, PhD, IOA Director and CNDR Co-Director. “People who are not working in ADRD can get involved in this field. Penn is a hotbed of aging research, but there is always room to do more.”

Read more here

More video interviews 

Full event lecture

Download flyer

Speakers

Jon Epstein: Welcome and Opening Remarks

Frances E. Jensen: "Neurosciences at Penn — Opportunities Overview"

Caryn Lerman: "PTNC Neuroscience Initiatives"

John Q. Trojanowski: "New NIA Funding for Research on Alzheimer's and Related Disorders"

Jerry Schellenberg: "Introduction to Penn Neurodegeneration Genomics Center"

Jim Eberwine/Frances E. Jensen: "BRAIN Initiative Funding, Research, and Collaborative Opportunities" 

Close section


Presentation Slides

John Q. Trojanowski: "New NIA Funding for Research on Alzheimer's and Related Disorders"​

Jerry Schellenberg: "Introduction to Penn Neurodegeneration Genomics Center (PNGC)"

Close section


Virtual Tours

Take a behind-the-scenes look at some of the groundbreaking research on Alzheimer's disease and related disorders being conducted here at Penn Medicine:

Virtual Tours:

University of Pennsylvania's Alzheimer's Disease Core Center (ADCC)

University of Pennsylvania's Udall Center for Parkinson's Research

University of Pennsylvania's Frontotemporal Degeneration (FTD) Program Project Grant (PPG) and FTD Center

 

Close section


Funding Opportunities

Current NIH Funding Opportunities

  • PAR-15-349 Health Disparities and Alzheimer’s Disease (R01)
  • PAR-15-350 Emerging Directions for Addressing Health Disparities in Alzheimer’s Disease (R03)
  • PAR-15-348 Research on Informal and Formal Caregiving for Alzheimer’s Disease (R01)
  • PAR-15-351 Research on Informal and Formal Caregiving for Alzheimer’s Disease (R21)
  • PAR-15-364 Phase III Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01)
  • PAR-15-356 Major Opportunities for Research in Epidemiology of Alzheimer’s Disease and Cognitive Resilience (R01)
  • PAR-15-357 Understanding Alzheimer’s Disease in the Context of the Aging Brain (R01)
  • PAR-15-358 Capturing Complexity in the Molecular and Cellular Mechanisms Involved in the Etiology of Alzheimer’s Disease (R01)
  • PAR- 15-359 Novel Approaches to Diagnosing Alzheimer’s Disease & Predicting Progression (R01)
  • PAR-15-365 Pilot Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01)
  • PAR-09054 Zenith Fellows Award Program
  • RFA-AG-17-009  Impact of Aging in Human Cell Models of Alzheimer's Disease (R01)
  • PAR-16-205  The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family Based Study (FBS) (U24)
  • PAR- 55205 Academic Drug Discovery and Development Program
  • RFA-NS-16-023 Center without Walls for the Identification and Validation of Molecular Mechanisms Contributing to Tau Pathogenesis and Associated Neurodegeneration in Frontotemporal Degeneration (FTD) (U54)
  • RFA-AG-17-050 Role of Peripheral Proteostasis on Brain Aging and on Alzheimer's Disease (R01)
  • RFA-AG-17-057 Systems Biology Approaches to Alzheimer's Disease Using Non-Mammalian Laboratory Animals (R01)
  • RFA-AG-17-055 Brain Lymphatic System in Aging and Alzheimer's Disease (R01)
  • RFA-AG-17-053 Human Cell Biology of Genetic Variants in Alzheimer's Disease (R01)
  • PAR-17-029 Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimer's Disease (R01)
  • PAS-17-026 Improving Quality of Care and Quality of Life for Persons with Alzheimer's Disease and Related Dementias at the End of Life (R03)
  • PAS-17-027 Improving Quality of Care and Quality of Life for Persons with Alzheimer's Disease and Related Dementias at the End of Life (R01) 
  • PAS-17-028 Common Mechanisms & Interactions Among Neurodegenerative Diseases (R01)
  • RFA-NS-17-016 Leveraging Existing Resources for Research on Lewy Body Dementia (R03)
  • PAR-17-067 Tools for Clinical Care and Management of Alzheimer's Disease (AD) and its Comorbidities (R43/R44)
  • PAR-17-066 Tools for Clinical Care and Management of Alzheimer's Disease (AD) and its Comorbidities (R41/R42)
  • PAS-17-064 Advancing Research on Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) (R43/R44)
  • PAS-17-065 Advancing Research on Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) (R42/R42)
  • RFA-AG-17-063 Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32)

Please check back periodically for newly added funding opportunities.

You can also subscribe to the National Institutes of Health (NIH) Guide LISTSERV to receive official updates on grant policies, guidelines, and funding opportunities. 

Close section


ADRD Grants at Penn

NIH-funded ADRD Grants at Penn

NIA Funded

NINDS Funded

Close section


Contacts

Institute on Aging
 aging@mail.med.upenn.edu

Center for Neurodegenerative Disease Research
 daviesk@upenn.edu
Website

Penn Medicine Translational Neuroscience Center
Website

Close section